Loading clinical trials...
Loading clinical trials...
A 2-Year Study (1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain) to Assess the Safety, Tolerability and Efficacy of Taranabant (MK0364) in Obese Patients Followed by a 1-Year Extension
Conditions
Interventions
Comparator: taranabant
Comparator: placebo
Start Date
July 1, 2005
Primary Completion Date
February 1, 2008
Completion Date
December 1, 2008
Last Updated
April 3, 2015
NCT07472881
NCT01143454
NCT07010757
NCT06223555
NCT06989203
NCT07237750
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions